23 results match your criteria: "Orbassano and Infermi Hospital[Affiliation]"

: Percutaneous left-atrial appendage (LAA) occlusion is an important therapeutic option for preventing cardioembolic stroke in patients with non-valvular atrial fibrillation (AF) at high risk of thromboembolic events and with contraindications for oral anticoagulation (OAC). It is usually performed with transesophageal echocardiography (TOE) guidance under general anesthesia (GA). In this retrospective study, we present a multicenter experience of LAA occlusion performed with conscious sedation (CS) without an anesthesiologist on site.

View Article and Find Full Text PDF

To test whether quantitative flow ratio (QFR)-based trans-stent gradient (TSG) is associated with adverse clinical events at follow-up. A post-hoc analysis of the multi-center HAWKEYE study was performed. Vessels post-PCI were divided into four groups (G) as follows: G1: QFR ≥ 0.

View Article and Find Full Text PDF

Background: The efficacy of posterior wall isolation (PWI) on top of pulmonary vein isolation (PVI) in patients affected by persistent atrial fibrillation (AF) is still controversial and little is known about the impact of contact-force (CF) technology.

Objective: In this retrospective study, we present our experience with PWI using CF sensing catheters and its efficacy and safety as an adjunctive ablation strategy on top of PVI for management of patients with persistent and longstanding persistent AF.

Methods: A total of 73 consecutive patients (20.

View Article and Find Full Text PDF

Purpose: Wire-based coronary physiology pullback performed before percutaneous coronary intervention (PCI) discriminates coronary artery disease (CAD) distribution and extent, and is able to predict functional PCI result. No research investigated if quantitative flow ratio (QFR)-based physiology assessment is able to provide similar information.

Methods: In 111 patients (120 vessels) treated with PCI, QFR was measured both before and after PCI.

View Article and Find Full Text PDF

Background Women represent an increasing percentage of interventional cardiologists in Italy compared with other countries. However, gaps exist in understanding and adapting to the impact of these changing demographics. Methods and Results We performed a national survey to analyze demographics, gender-based professional difference, needs in terms of catheterization laboratory (Cath-Lab) abstention, and radiation safety issues in Italian Cath-Lab settings.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the risks of recurring ischemia and bleeding in patients treated for acute coronary syndrome (ACS) with percutaneous coronary intervention (PCI) over the first year after the procedure.
  • Two large registries, BleeMACS and RENAMI, were used to compare the average daily ischemic risk (ADIR) and average daily bleeding risk (ADBR) among nearly 20,000 patients receiving different antiplatelet therapies.
  • Results showed that while ADIR was generally greater than ADBR in the initial weeks post-PCI (especially for severe cases), this trend shifted, with higher bleeding risks found in specific groups like non-ST-segment elevation ACS patients and those on ticagrelor after three months
View Article and Find Full Text PDF
Article Synopsis
  • The PRECISE-DAPT and PARIS risk scores were created to help doctors decide on the best duration for dual antiplatelet therapy (DAPT) after heart procedures, but these scores were not tested in patients with acute coronary syndrome (ACS) using recent medications like prasugrel or ticagrelor.
  • A study involving 4,424 ACS patients who had percutaneous coronary interventions was conducted, measuring how well these risk scores predicted major bleeding and ischemic events during an average follow-up of 14 months.
  • The findings showed that PRECISE-DAPT was more effective in predicting major bleeding incidents, while the PARIS ischemic risk score was better at predicting ischemic
View Article and Find Full Text PDF
Article Synopsis
  • This study compares the effectiveness and safety of clopidogrel, prasugrel, and ticagrelor in over 19,000 patients with acute coronary syndrome undergoing PCI and looks at the risks of ischemic events and bleeding over time.
  • Results show prasugrel leads to significantly lower rates of net adverse clinical events and major adverse cardiovascular events compared to clopidogrel, while ticagrelor also reduces major adverse cardiovascular events but has a higher bleeding risk.
  • The analysis indicates that clopidogrel’s risk profile peaks at 3 months for ischemic events while prasugrel maintains a balance between ischemia and bleeding, and ticagrelor consistently reduces heart attacks over
View Article and Find Full Text PDF

Prognostic Value of QFR Measured Immediately After Successful Stent Implantation: The International Multicenter Prospective HAWKEYE Study.

JACC Cardiovasc Interv

October 2019

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy; Maria Cecilia Hospital, GVM Care & Research, Cotignola, Italy. Electronic address:

Objectives: The aim of this study was to investigate the potential role of post-percutaneous coronary intervention (PCI) quantitative flow ratio (QFR) measurements to predict clinical outcomes in patients with successful PCI.

Background: The prognostic value of QFR measured immediately after PCI has not been prospectively investigated.

Methods: Patients undergoing complete revascularization with successful PCI and stent implantation were eligible for acquisition of projections for QFR computation.

View Article and Find Full Text PDF

Randomised trials have demonstrated higher midterm rates of adverse events and device thrombosis with Absorb-BVS compared to contemporary drug-eluting-stents (DES). BVS failure was ascribed to the implantation technique and consequently two large randomised trials evaluated the clinical impact of an optimised scaffold-implant-procedure. However, pooling together data from ABSORB-IV and those of the COMPARE-ABSORB, the scaffold was still associated with a statistically significant increased risk of target-vessel myocardial-infarction (OR 1.

View Article and Find Full Text PDF
Article Synopsis
  • The text discusses the significance of the first author's name in scholarly works.
  • It highlights how the first author typically represents the main contributor to the research or study.
  • The importance of proper citation and recognition in academic settings is emphasized throughout.
View Article and Find Full Text PDF

Background: Limited data are available concerning differences in clinical outcomes for real-life patients treated with ticagrelor versus prasugrel after percutaneous coronary intervention (PCI).

Objective: Our objective was to determine and compare the efficacy and safety of ticagrelor and prasugrel in a real-world population.

Methods: RENAMI was a retrospective, observational registry including the data and outcomes of consecutive patients with acute coronary syndrome (ACS) who underwent primary PCI and were discharged with dual antiplatelet therapy (DAPT) between January 2012 and January 2016.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of different durations of dual antiplatelet therapy (DAPT) using prasugrel or ticagrelor in patients with acute coronary syndromes who underwent percutaneous coronary intervention, as previous research primarily focused on clopidogrel.
  • Researchers analyzed data from 4424 patients, categorizing them into three groups based on DAPT duration: less than 12 months, exactly 12 months, and more than 12 months, to assess net adverse clinical events (NACEs) and major adverse cardiac events (MACEs).
  • Findings showed that patients on 12 months or longer of DAPT had a significantly lower risk of NACEs and MACEs compared to those receiving less than 12
View Article and Find Full Text PDF

Background: Percutaneous coronary intervention (PCI) has been established as an alternative treatment option to coronary artery by-pass graft (CABG) surgery in patients with left main coronary artery disease (LMCAD). Whether the findings of randomized controlled trials are applicable to a real-world patient population is unclear.

Methods: We compared the outcomes of PCI with new-generation DES in the all-comer, international, multicenter DELTA-2 registry retrospectively evaluating mid-term clinical outcomes with the historical CABG cohort enrolled in the DELTA-1 registry according to the EXCEL key inclusion or exclusion criteria.

View Article and Find Full Text PDF

Introduction: The efficacy and safety of switching P2Y receptor antagonists in patients admitted for acute coronary syndrome (ACS) remain unclear. We assessed the short-term clinical outcomes (in-hospital and within 30 days) of switching P2Y inhibitor (P2YI) drugs versus maintaining the same regimen by performing a comprehensive review and meta-analysis of available data.

Methods: MEDLINE/PubMed/SCOPUS/Cochrane databases were screened for studies regarding switching of P2YI in patients with ACS that reported 30 days follow-up.

View Article and Find Full Text PDF
Article Synopsis
  • - The study assessed the occurrence and predictors of major bleeding in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention (PCI) and were treated with prasugrel or ticagrelor.
  • - Out of 4424 patients, 1.8% experienced significant bleeding after about 14 months, which was linked to higher rates of major adverse cardiovascular events (MACE) and death.
  • - Older adults (over 75 years) and women were identified as independent risk factors for major bleeding, suggesting a need for personalized antiplatelet therapy strategies in these groups.
View Article and Find Full Text PDF

Introduction: Ticagrelor and prasugrel are recommended as first line therapy in patients with acute coronary syndromes (ACS). However, patients with anemia are commonly treated with clopidogrel in routine clinical practice. The RENAMI registry (REgistry of New Antiplatelet therapy in patients with acute Myocardial Infarction) included ACS patients treated with prasugrel or ticagrelor at hospital discharge.

View Article and Find Full Text PDF

Objectives: The aim of this study was to evaluate clinical outcomes of unprotected left main coronary artery percutaneous coronary intervention (PCI) with new-generation drug-eluting stents in a "real world" population.

Background: PCI of the unprotected left main coronary artery is currently recommended as an alternative to coronary artery bypass grafting (CABG) in selected patients.

Methods: All consecutive patients with unprotected left main coronary artery stenosis treated by PCI with second-generation drug-eluting stents were analyzed in this international, all-comers, multicenter registry.

View Article and Find Full Text PDF

Bioresorbable vascular scaffolds (BRS) represent the latest innovation in the field of interventional cardiology. BRS have recently been introduced in routine clinical practice and their use has progressively extended in everyday clinical practice. The BRS use appears theoretically attractive in patients presenting with acute coronary syndromes (ACS) as they are generally young with long life expectancy, thus possibly benefiting more of the so-called vascular reparative therapy.

View Article and Find Full Text PDF

Aim: To compare in patients with ACS (acute coronary syndromes) a PCI (percutaneous coronary intervention) approach based on FFR (fractional flow reserve) vs. one based on OCT (optical coherence tomography).

Methods And Results: Consecutive patients admitted for ACS and treated with a PCI approach based on OCT or on FFR (recruited in two different studies) were compared and matched with propensity score analysis.

View Article and Find Full Text PDF

Background: In diabetic patients a predisposed coronary microcirculation along with a higher risk of distal particulate embolization during primary percutaneous intervention (PCI) increases the risk of peri-procedural microcirculatory damage. However, new antiplatelet agents, in particular Ticagrelor, may protect the microcirculation through its adenosine-mediated vasodilatory effects.

Methods: PREDICT is an original, prospective, randomized, multicenter controlled study designed to investigate the protective effect of Ticagrelor on the microcirculation during PCI in patient with diabetes mellitus type 2 or pre-diabetic status.

View Article and Find Full Text PDF

Unlabelled: Coronary artery aneurysm is defined as a coronary dilation that exceeds the diameter of adjacent segments or the diameter of the patient's largest normal coronary vessel by 1.5×. It is an uncommon disease that has been diagnosed with increasing frequency since the widespread appearance of coronary angiography.

View Article and Find Full Text PDF